Scholarlink

Objective <p>To compare labour duration and the effectiveness of cervical ripening by transcervical balloon versus oral misoprostol in women with elevated body mass index (BMI ≥ 25&#xa0;kg/m<sup>2</sup>).</p> Methods <p>A retrospective single-centre cohort (2022–2024) at Montpellier University Hospital including singleton term pregnancies (37–42&#xa0;weeks) with cephalic presentation, BMI &gt; 25 and Bishop score &lt; 6. Mechanical balloon versus oral misoprostol (25&#xa0;µg/2&#xa0;h or 50&#xa0;µg/4&#xa0;h) were compared by survival analysis assessing induction-to-delivery interval and by logistic regression assessing vaginal delivery rates, all adjusting for key covariates. Exclusion criteria: maternal age &lt; 18&#xa0;years, scarred uterus, low-lying placenta.</p> Results <p>Among 7336 births, 2225 (30.3%) underwent labour induction, of which 247 met inclusion criteria. Vaginal delivery occurred in 180/247 (72.9%), of which 21/180(11.7%) were operative vaginal, caesareans were 67/247(27.1%), with no statistically significant difference observed; the study was not powered to assess equivalence of caesarean rates. Balloons achieved shorter induction-to-delivery (Mean 25.5&#xa0;h; 95%CI 23.8–27.2&#xa0;h vs. 35.3&#xa0;h; 95%CI 33.0–37.6&#xa0;h; <i>p &lt; </i>0.001), and induction-to-active-phase intervals vs. misoprostol (Mean 21.1&#xa0;h; SD 12.8&#xa0;h vs. 30.3&#xa0;h; SD 17.7&#xa0;h; <i>p &lt; </i>0.001), without difference in first active-stage and second-stage duration or among misoprostol regimens. Cox regression identified predictors of longer induction-to-delivery: nulliparity (HR:0.31; 95%CI 0.22–0.42), misoprostol (HR:0.46; 95%CI 0.33–0.66) vs intrauterine balloons, LGA (HR:0.63; 95%CI 0.43–0.92), higher BMI (HR:0.97; 95%CI 0.97–1.00), and excessive weight gain (HR:0.98; 95%CI 0.95–1.00). Treatment-by-parity and treatment-by-Bishop score interactions were not significant. A Fine and Gray competing-risks model showed that mechanical ripening vs. misoprostol provided shorter time intervals from induction to delivery (<i>p = </i>0.033) and to active phase (<i>p = </i>0.003). After one cycle of ripening, oxytocin infusion was associated with a higher rate of vaginal birth compared with repeated ripening (sHR 2.28, 95%CI 1.49–3.49). PPH or adverse neonatal outcomes were not different.</p> Conclusions <p>In a high-BMI population mechanical cervical ripening vs. oral misoprostol show similar effectiveness, with the first associated with a shorter duration of labour induction.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Cervical ripening with mechanical method vs oral misoprostol in pregnancies with elevated BMI: a cohort study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月27日

查看全文
  • Maria Castoldi,
  • Florent Fuchs,
  • Philippe Deruelle,
  • Giulia Maria Scotti,
  • Massimo Candiani,
  • Paolo Ivo Cavoretto

摘要

Objective

To compare labour duration and the effectiveness of cervical ripening by transcervical balloon versus oral misoprostol in women with elevated body mass index (BMI ≥ 25 kg/m2).

Methods

A retrospective single-centre cohort (2022–2024) at Montpellier University Hospital including singleton term pregnancies (37–42 weeks) with cephalic presentation, BMI > 25 and Bishop score < 6. Mechanical balloon versus oral misoprostol (25 µg/2 h or 50 µg/4 h) were compared by survival analysis assessing induction-to-delivery interval and by logistic regression assessing vaginal delivery rates, all adjusting for key covariates. Exclusion criteria: maternal age < 18 years, scarred uterus, low-lying placenta.

Results

Among 7336 births, 2225 (30.3%) underwent labour induction, of which 247 met inclusion criteria. Vaginal delivery occurred in 180/247 (72.9%), of which 21/180(11.7%) were operative vaginal, caesareans were 67/247(27.1%), with no statistically significant difference observed; the study was not powered to assess equivalence of caesarean rates. Balloons achieved shorter induction-to-delivery (Mean 25.5 h; 95%CI 23.8–27.2 h vs. 35.3 h; 95%CI 33.0–37.6 h; p < 0.001), and induction-to-active-phase intervals vs. misoprostol (Mean 21.1 h; SD 12.8 h vs. 30.3 h; SD 17.7 h; p < 0.001), without difference in first active-stage and second-stage duration or among misoprostol regimens. Cox regression identified predictors of longer induction-to-delivery: nulliparity (HR:0.31; 95%CI 0.22–0.42), misoprostol (HR:0.46; 95%CI 0.33–0.66) vs intrauterine balloons, LGA (HR:0.63; 95%CI 0.43–0.92), higher BMI (HR:0.97; 95%CI 0.97–1.00), and excessive weight gain (HR:0.98; 95%CI 0.95–1.00). Treatment-by-parity and treatment-by-Bishop score interactions were not significant. A Fine and Gray competing-risks model showed that mechanical ripening vs. misoprostol provided shorter time intervals from induction to delivery (p = 0.033) and to active phase (p = 0.003). After one cycle of ripening, oxytocin infusion was associated with a higher rate of vaginal birth compared with repeated ripening (sHR 2.28, 95%CI 1.49–3.49). PPH or adverse neonatal outcomes were not different.

Conclusions

In a high-BMI population mechanical cervical ripening vs. oral misoprostol show similar effectiveness, with the first associated with a shorter duration of labour induction.